MedTrace Logo

The Clinical Efficacy of Next Science Wound Gel (NXTSC) in the Healing of Chronic Wounds

NCT02465073 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2019-11-25

Study results available
· View outcomes & findings →

Summary

Determine the effect on wound treatment outcomes using a novel antimicrobial wound gel (NXTSC) for the treatment of infected wounds as the sole topical treatment of microbial infection at the wound site.

Conditions

  • Wound Infection

Interventions

DEVICE

NXTSC wound gel

Subjects will receive NXTSC wound gel only.

DEVICE

NXTSC wound gel plus Standard of Care

Subjects will be randomized to the NXTSC wound gel plus Standard of Care of only.

DEVICE

Standard of Care Group

Subjects will receive Standard of Care only.

Sponsors & Collaborators

  • Next Science TM

    collaborator INDUSTRY

  • Southwest Regional Wound Care Center

    lead OTHER

Principal Investigators

  • Randall D Wolcott, M.D. · Southwest Regional Wound Care Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02465073 on ClinicalTrials.gov